Wall Street closed a volatile session on Monday, August 3, sifting through last week's payrolls miss and a summer earnings sprint. The macro backdrop is unchanged from the July 29 Federal Open Market Committee statement: Chair Kevin Warsh's committee held the target range at 3.50%-3.75% and said financial conditions have "eased substantially" since June 17. CME Group's FedWatch tool still assigns roughly an 80% probability to zero additional cuts through the balance of 2026, keeping investors focused on company fundamentals. August 3 delivered a fresh wave of upgrades from Truist, Evercore ISI, JP Morgan, Needham, and Stifel — tied to margin timing, valuation resets, or earnings beats. The five names below all received Buy-equivalent upgrades on August 3.
Corning (GLW) — Truist calls the July pullback a gift for AI infrastructure exposure
Corning is a specialty glass, ceramics, and optical fiber maker whose products sit inside data-center networking cables, smartphones, and displays. On August 3, Truist Securities analyst Matthew Niknam upgraded from Hold to Buy with a $175 target (down from $205), writing that "we have waited for a more reasonable entry point to get more constructive, and we now have one." The note cites a 45% drop from the year-to-date high through late July, AI data-center optical demand, hyperscaler exposure through Photonics MAP, and guidance for 18% revenue growth through 2028 with operating margins reaching 26%.
Shares closed at $147.45 on August 3, up 6.65% on the day, with a market cap of $126.9 billion and a trailing P/E of 54.81. The 52-week range is $62.65 to $271.78. The consensus rating is Buy, with 7 of 10 covering analysts bullish, an average target of $192, a median of $190, a high of $243, and a low of $129.
Risks: A slowdown in hyperscaler AI capex, continued softness in consumer electronics glass, and elevated valuation on a trailing P/E basis. Morgan Stanley's Meta Marshall maintains an Equal-Weight rating with a $165 target, arguing that Corning's near-term earnings power does not yet justify a growth multiple.
Eaton (ETN) — Evercore ISI sees the margin bottom in early 2026
Eaton is a diversified power management company whose electrical products benefit from data-center buildout, electrification, and grid-modernization spending. On August 3, Evercore ISI analyst David Raso upgraded from In-Line to Outperform, raising his target to $502 from $453. His view: Q1 and Q2 of 2026 mark the low point for year-over-year EPS growth, with margin expansion returning by Q4 2026 and easy comparisons through summer 2027. Q2 adjusted EPS of $3.15 topped $3.07 consensus on revenue of $8.5 billion versus $8.16 billion, and backlog now covers 76% of Eaton's 2026 electrical sales guide. RBC Capital and BMO reiterated Outperform the same day at $512 and $487.
Shares closed at $435.47 on August 3, up 4.88%, with a market cap of $169.1 billion and a trailing P/E of 35.81. The 52-week range is $311.92 to $436.74. The consensus rating is Buy, with 8 of 11 covering analysts bullish, an average target of $445.82, a median of $445, a high of $512, and a low of $360.
Risks: A softer-than-expected mobility spin-off scheduled for early 2027, digestion of AI capacity already ordered, and the fact that shares closed within 30 cents of the 52-week high. Barclays' Julian Mitchell holds Equal-Weight with a $354 target.
Ingersoll-Rand (IR) — Stifel finally warms to a "high-quality industrial compounder"
Ingersoll-Rand makes air compressors, blowers, pumps, and vacuum systems for industrial, medical, and life-science customers. On August 3, Stifel analyst Nathan Jones upgraded from Hold to Buy with a $101 target (up from $84), citing longer-cycle order progression, volume leverage plus pricing driving margin expansion, and M&A flexibility, and calling the company a "high-quality industrial compounder." Q2 adjusted EPS came in at $0.86 versus $0.83 consensus on $2.05 billion of revenue versus $1.96 billion. Baird's Michael Halloran reiterated Outperform the same day at $109.
Shares closed at $86.39 on August 3, up 3.61%, with a market cap of $33.8 billion and a trailing P/E of 25.48. The 52-week range is $68.07 to $100.96. The consensus rating is Buy, with 4 of 7 covering analysts bullish, an average target of $94.14, a median of $94, a high of $109, and a low of $80.
Risks: A slowdown in industrial capital spending, integration risk from bolt-on M&A, and lingering pricing pressure in the life-science tools end market. Morgan Stanley's Chris Snyder holds an Equal-Weight rating with an $80 target, the low end of the coverage universe.
LyondellBasell (LYB) — JP Morgan flips constructive on cash flow
LyondellBasell is one of the world's largest chemical companies, making polyolefins, refining products, and advanced polymers. On August 3, JP Morgan analyst Jeffrey Zekauskas upgraded from Neutral to Overweight with an $80 target (up from $75). His thesis centers on cash flow: free cash flow yield of 12% to 14%, and net debt to EBITDA declining to 1.7 times in 2026 from 3.7 times in 2025. Zekauskas models normalized EBITDA around $5 billion for 2028, and Q2 EBITDA of $2.1 billion annualizes at $8.4 billion. Shares trade at roughly 5.2, 5.5, and 5.0 times EBITDA for 2026-2028 estimates.
Shares closed at $60.99 on August 3, down 1.76%, with a market cap of $19.7 billion and a trailing P/E of 32.79. The 52-week range is $41.58 to $83.94. The trailing dividend yield sits near 7%. The consensus rating is Buy, with 6 of 12 covering analysts bullish, an average target of $74.50, a median of $72.50, a high of $98, and a low of $48.
Risks: A weaker-than-expected polyethylene pricing environment, dividend sustainability if EBITDA does not normalize on schedule, and the fact that shares have already climbed 46% year-to-date. BMO Capital's John McNulty carries a Market Perform rating with a $68 target, reflecting continued caution on chemical margins.
Proto Labs (PRLB) — Needham upgrades on demand for on-shored, on-demand manufacturing
Proto Labs is a digital manufacturer that produces custom parts via injection molding, CNC machining, 3D printing, and sheet-metal fabrication for engineers and product-development teams. On August 3, Needham analyst James Ricchiuti upgraded from Hold to Buy with a fresh $87 target. The move builds on Benchmark's Robert Wasserman, whose $91 target published July 6 flagged accelerating quote-to-order conversion and tariff-driven reshoring of aerospace, defense, and medical device prototyping.
Shares closed at $80.39 on August 3, up 7.12%, with a market cap of $1.9 billion and a trailing P/E of 43.22. The 52-week range is $42.84 to $83.15. The stock does not pay a dividend. Consensus is thin — Benchmark's Buy at $91 is the only rating currently in the data set, pending Needham's note.
Risks: A cyclical downturn in prototyping demand, competitive pressure from Xometry and captive service bureaus, and gross-margin compression from lower-margin 3D printing services. Shares trade near the top of the 52-week range, so entry-point discipline matters.
Found this helpful? Share it with others.